CHAPTER 1: INTRODUCTION

1.1. Report description
1.2. Key benefits for stakeholders
1.3. Key market segments
1.4. Research methodology

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

2.1. Key findings of the study
2.2. CXO perspective

CHAPTER 3: MARKET OVERVIEW

3.1. Market definition and scope
3.2. Key findings

3.2.1. Top winning strategies
3.2.2. Top investment pockets

3.3. Top player positioning, 2017
3.4. Market dynamics

3.4.1. Drivers

3.4.1.1. Rise in funds for biobanks
3.4.1.2. Increase in R&D activities for application of biobank specimens
3.4.1.3. Surge in prevalence of fatal chronic diseases

3.4.2. Restraints

3.4.2.1. Legal and ethical issues
3.4.2.2. Lack of awareness regarding biobanking

3.4.3. Opportunity

3.4.3.1. Untapped opportunities in the developing regions

3.4.4. Impact analyses

CHAPTER 4: BIOBANKING MARKET, BY SPECIMEN TYPE

4.1. Overview

4.1.1. Market size and forecast

4.2. Blood products

4.2.1. Market size and forecast, by region
4.2.2. Market analysis, by country

4.3. Solid tissues

4.3.1. Market size and forecast, by region
4.3.2. Market analysis, by country

4.4. Cell lines

4.4.1. Market size and forecast, by region
4.4.2. Market analysis, by country

4.5. Others

4.5.1. Market size and forecast, by region
4.5.2. Market analysis, by country

CHAPTER 5: BIOBANKING MARKET, BY TYPE OF BIOBANK

5.1. Overview

5.1.1. Market size and forecast

5.2. Population-based biobanks

5.2.1. Market size and forecast, by region
5.2.2. Market analysis, by country

5.3. Disease-oriented biobanks

5.3.1. Market size and forecast, by region
5.3.2. Market analysis, by country

CHAPTER 6: BIOBANKING MARKET, BY OWNERSHIP

6.1. Overview

6.1.1. Market size and forecast

6.2. National/regional agencies

6.2.1. Market size and forecast, by region
6.2.2. Market analysis, by country

6.3. Nonprofit organization

6.3.1. Market size and forecast, by region
6.3.2. Market analysis, by country

6.4. University

6.4.1. Market size and forecast, by region
6.4.2. Market analysis, by country

6.5. Private organization

6.5.1. Market size and forecast, by region
6.5.2. Market analysis, by country

CHAPTER 7: BIOBANKING MARKET, BY APPLICATION

7.1. Overview

7.1.1. Market size and forecast

7.2. Therapeutic

7.2.1. Market size and forecast, by region
7.2.2. Market analysis, by country

7.3. Research

7.3.1. Market size and forecast, by region
7.3.2. Market analysis, by country

CHAPTER 8: BIOBANKING MARKET, BY REGION

8.1. Overview

8.1.1. Market size and forecast

8.2. North America

8.2.1. Key market trends, growth factors, and opportunities
8.2.2. North America market size and forecast, by country

8.2.2.1. U.S. biobanking market size and forecast

8.2.2.1.1. U.S. biobanking market size and forecast, by specimen type
8.2.2.1.2. U.S. biobanking market size and forecast, by type of biobank
8.2.2.1.3. U.S. biobanking market size and forecast, by ownership
8.2.2.1.4. U.S. biobanking market size and forecast, by application

8.2.2.2. Canada biobanking market size and forecast

8.2.2.2.1. Canada biobanking market size and forecast, by specimen type
8.2.2.2.2. Canada biobanking market size and forecast, by type of biobank
8.2.2.2.3. Canada biobanking market size and forecast, by ownership
8.2.2.2.4. Canada biobanking market size and forecast, by application

8.2.2.3. Mexico biobanking market size and forecast

8.2.2.3.1. Mexico biobanking market size and forecast, by specimen type
8.2.2.3.2. Mexico biobanking market size and forecast, by type of biobank
8.2.2.3.3. Mexico biobanking market size and forecast, by ownership
8.2.2.3.4. Mexico biobanking market size and forecast, by application

8.2.3. North America market size and forecast, by specimen type
8.2.4. North America market size and forecast, by type of biobank
8.2.5. North America biobanking market size and forecast, by ownership
8.2.6. North America biobanking market size and forecast, by application

8.3. Europe

8.3.1. Key market trends, growth factors, and opportunities
8.3.2. Europe market size and forecast, by country

8.3.2.1. Germany biobanking market size and forecast

8.3.2.1.1. Germany biobanking market size and forecast, by specimen type
8.3.2.1.2. Germany biobanking market size and forecast, by type of biobank
8.3.2.1.3. Germany biobanking market size and forecast, by ownership
8.3.2.1.4. Germany biobanking market size and forecast, by application

8.3.2.2. France biobanking market size and forecast

8.3.2.2.1. France biobanking market size and forecast, by specimen type
8.3.2.2.2. France biobanking market size and forecast, by type of biobank
8.3.2.2.3. France biobanking market size and forecast, by ownership
8.3.2.2.4. France biobanking market size and forecast, by application

8.3.2.3. UK biobanking market size and forecast

8.3.2.3.1. UK biobanking market size and forecast, by specimen type
8.3.2.3.2. UK biobanking market size and forecast, by type of biobank
8.3.2.3.3. UK biobanking market size and forecast, by ownership
8.3.2.3.4. UK biobanking market size and forecast, by application

8.3.2.4. Italy biobanking market size and forecast

8.3.2.4.1. Italy biobanking market size and forecast, by specimen type
8.3.2.4.2. Italy biobanking market size and forecast, by type of biobank
8.3.2.4.3. Italy biobanking market size and forecast, by ownership
8.3.2.4.4. Italy biobanking market size and forecast, by application

8.3.2.5. Spain biobanking market size and forecast

8.3.2.5.1. Spain biobanking market size and forecast, by specimen type
8.3.2.5.2. Spain biobanking market size and forecast, by type of biobank
8.3.2.5.3. Spain biobanking market size and forecast, by ownership
8.3.2.5.4. Spain biobanking market size and forecast, by application

8.3.2.6. Rest of Europe biobanking market size and forecast

8.3.2.6.1. Rest of Europe biobanking market size and forecast, by specimen type
8.3.2.6.2. Rest of Europe biobanking market size and forecast, by type of biobank
8.3.2.6.3. Rest of Europe biobanking market size and forecast, by ownership
8.3.2.6.4. Rest of Europe biobanking market size and forecast, by application

8.3.3. Europe market size and forecast, by specimen type
8.3.4. Europe market size and forecast, by type of biobank
8.3.5. Europe biobanking market size and forecast, by ownership
8.3.6. Europe biobanking market size and forecast, by application

8.4. Asia-Pacific

8.4.1. Key market trends, growth factors, and opportunities
8.4.2. Asia-Pacific market size and forecast, by country

8.4.2.1. Japan biobanking market size and forecast

8.4.2.1.1. Japan biobanking market size and forecast, by specimen type
8.4.2.1.2. Japan biobanking market size and forecast, by type of biobank
8.4.2.1.3. Japan biobanking market size and forecast, by ownership
8.4.2.1.4. Japan biobanking market size and forecast, by application

8.4.2.2. China biobanking market size and forecast

8.4.2.2.1. China biobanking market size and forecast, by specimen type
8.4.2.2.2. China biobanking market size and forecast, by type of biobank
8.4.2.2.3. China biobanking market size and forecast, by ownership
8.4.2.2.4. China biobanking market size and forecast, by application

8.4.2.3. India biobanking market size and forecast

8.4.2.3.1. India biobanking market size and forecast, by specimen type
8.4.2.3.2. India biobanking market size and forecast, by type of biobank
8.4.2.3.3. India biobanking market size and forecast, by ownership
8.4.2.3.4. India biobanking market size and forecast, by application

8.4.2.4. Australia biobanking market size and forecast

8.4.2.4.1. Australia biobanking market size and forecast, by specimen type
8.4.2.4.2. Australia biobanking market size and forecast, by type of biobank
8.4.2.4.3. Australia biobanking market size and forecast, by ownership
8.4.2.4.4. Australia biobanking market size and forecast, by application

8.4.2.5. Rest of Asia-Pacific biobanking market size and forecast

8.4.2.5.1. Rest of Asia-Pacific biobanking market size and forecast, by specimen type
8.4.2.5.2. Rest of Asia-Pacific biobanking market size and forecast, by type of biobank
8.4.2.5.3. Rest of Asia-Pacific biobanking market size and forecast, by ownership
8.4.2.5.4. Rest of Asia-Pacific biobanking market size and forecast, by application

8.4.3. Asia-Pacific market size and forecast, by specimen type
8.4.4. Asia-Pacific market size and forecast, by type of biobank
8.4.5. Asia-Pacific biobanking market size and forecast, by ownership
8.4.6. Asia-Pacific biobanking market size and forecast, by application

8.5. LAMEA

8.5.1. Key market trends, growth factors, and opportunities
8.5.2. LAMEA market size and forecast, by country

8.5.2.1. Brazil biobanking market size and forecast

8.5.2.1.1. Brazil biobanking market size and forecast, by specimen type
8.5.2.1.2. Brazil biobanking market size and forecast, by type of biobank
8.5.2.1.3. Brazil biobanking market size and forecast, by ownership
8.5.2.1.4. Brazil biobanking market size and forecast, by application

8.5.2.2. South Africa biobanking market size and forecast

8.5.2.2.1. South Africa biobanking market size and forecast, by specimen type
8.5.2.2.2. South Africa biobanking market size and forecast, by type of biobank
8.5.2.2.3. South Africa biobanking market size and forecast, by ownership
8.5.2.2.4. South Africa biobanking market size and forecast, by application

8.5.2.3. Saudi Arabia biobanking market size and forecast

8.5.2.3.1. Saudi Arabia biobanking market size and forecast, by specimen type
8.5.2.3.2. Saudi Arabia biobanking market size and forecast, by type of biobank
8.5.2.3.3. Saudi Arabia biobanking market size and forecast, by ownership
8.5.2.3.4. Saudi Arabia biobanking market size and forecast, by application

8.5.2.4. Rest of LAMEA biobanking market size and forecast

8.5.2.4.1. Rest of LAMEA biobanking market size and forecast, by specimen type
8.5.2.4.2. Rest of LAMEA biobanking market size and forecast, by type of biobank
8.5.2.4.3. Rest of LAMEA biobanking market size and forecast, by ownership
8.5.2.4.4. Rest of LAMEA biobanking market size and forecast, by application

8.5.3. LAMEA market size and forecast, by specimen type
8.5.4. LAMEA market size and forecast, by type of biobank
8.5.5. LAMEA biobanking market size and forecast, by ownership
8.5.6. LAMEA biobanking market size and forecast, by application

CHAPTER 9: COMPANY PROFILES

9.1. ASKION GmbH

9.1.1. Company overview
9.1.2. Company snapshot
9.1.3. Operating business segments
9.1.4. Product portfolio

9.2. CTI BIOTECH

9.2.1. Company overview
9.2.2. Company snapshot
9.2.3. Product portfolio

9.3. Cureline, Inc.

9.3.1. Company overview
9.3.2. Company snapshot
9.3.3. Product portfolio

9.4. Excilone SARL

9.4.1. Company overview
9.4.2. Company snapshot
9.4.3. Operating business segments
9.4.4. Product portfolio

9.5. Firalis S.A.

9.5.1. Company overview
9.5.2. Company snapshot
9.5.3. Operating business segments
9.5.4. Product portfolio

9.6. Hamilton Company

9.6.1. Company overview
9.6.2. Company snapshot
9.6.3. Operating business segments
9.6.4. Product portfolio

9.7. LabVantage Solutions, Inc.

9.7.1. Company overview
9.7.2. Company snapshot
9.7.3. Product portfolio
9.7.4. Key strategic moves and developments

9.8. LGC Limited

9.8.1. Company overview
9.8.2. Company snapshot
9.8.3. Operating business segments
9.8.4. Product portfolio
9.8.5. Business performance

9.9. PrecisionMed, Inc.

9.9.1. Company overview
9.9.2. Company snapshot
9.9.3. Product portfolio

9.10. ProMedDx, LLC

9.10.1. Company overview
9.10.2. Company snapshot
9.10.3. Product portfolio